Gene therapy company uniQure – once a frontrunner in the field – is facing trouble, with dwindling sales and major setbacks in research and development. The Danish firm, formerly known as Amsterdam Molecular Therapeutics, has had to slash its workforce and restructure in a bid to stay afloat. Trials for a potential Huntington’s disease treatment showed mixed results, and costs for its hemophilia drug, HEMGENIX, were considered too high.
Rapid7 Labs Identifies Malware Installer Targeting Chinese and Vietnamese Users
Rapid7 Labs has discovered a highly evasive malware installer called CleverSoar, which targets Chinese and Vietnamese-speaking users by deploying and protecting several malicious elements including
